为解决Prurigo Nodularis（PN）患者疾病负担评估不足及非生物制剂治疗满意度不明确的问题，研究人员开展了一项横断面调查PN TREK。研究通过132例美国PN患者的PROMs（患者报告结局指标）分析发现，WI-NRS≥7患者存在更严重的皮肤疼痛、睡眠障碍及生活质量（QoL ...

Prurigo nodularis is an extremely itchy skin condition. It causes a rash that often includes hard lumps called nodules. You might also hear it called nodular prurigo. Doctors don’t know exactly ...

Prurigo nodularis is a chronic skin condition that causes intensely itchy bumps. These hard lumps, called nodules, often appear on areas you can easily scratch, like your arms, legs, and upper back.

The story of chronic itch and its impact on quality of life is one dermatologists have heard often. Until recently, treatment ...

Dublin, May 26, 2025 (GLOBE NEWSWIRE) -- The "Prurigo Nodularis Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast, 2025-2035" report has been ...

Conversations in Dermatology: 2025 will focus on clinical challenges and recent advances that health care providers who manage chronic pruritic conditions should know.

1 “These results, alongside the OLYMPIA 2 trial data, formed the basis of nemolizumab’s recent U.S. Food and Drug Administration approval for the treatment of adults with prurigo nodularis.

Dublin, May 26, 2025 (GLOBE NEWSWIRE) -- The "Prurigo Nodularis Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast, 2025-2035" report has been ...

The U.S. Food and Drug Administration has approved Galderma's Nemluvio (nemolizumab) for adult patients living with prurigo nodularis. Nemluvio, administered as a prefilled pen for subcutaneous ...

Patients may self-inject Nemluvio after receiving training on SC injection technique. The Food and Drug Administration (FDA) has approved Nemluvio ® (nemolizumab-ilto) for the treatment of adults ...